All Articles

The global food expo leader is launching in Vietnam, tapping into Asia's new powerhouse to help diversify and strengthen fragile global supply chains.

Following a massive stock surge, Forte Biosciences is raising $150M. The funds are crucial for a pivotal year of clinical trials for its autoimmune drug.

The retailer posts modest annual growth despite a tough Q4, as international gains and efficiency drives offset major headwinds in its Canadian operations.

A new partnership automates flight receipt processing, a strategic move by Expensify to gain an edge in the competitive corporate travel tech market.

A little-known platform rocketed from $420k to $1.5B in three years. We explore the powerful tech engine behind this explosive rise in wealth management.

The deal merges a leading health data platform with mobile diagnostics, aiming to remove barriers to proactive wellness and deliver lab tests anywhere.

A minority-owned firm revives a 1920s Santa Ana property with modern luxury, highlighting a trend of historic preservation amid gentrification concerns.

A Texas firm opens a plant for a non-toxic chemical that boosts oil output and could turn old wells into a new source of critical minerals.

Jordan Foster Construction's latest award reveals a deeper trend: integrating mental health and AI to redefine safety in a high-risk industry.

With its lead drug in Phase 3 and a strong Biogen partnership, Stoke Therapeutics prepares to update investors on its disease-modifying Dravet syndrome therapy.

A new 50MW CO2 heat pump offers a path for factories and cities to ditch boilers. But can industry overcome the high cost and technical hurdles to adopt it?

With a $226M war chest from its SPAC merger, Suncrete (RMIX) is now public, planning to build a concrete empire in America's fastest-growing region.

Brazilian importers bypass high local credit costs using a Chinese state-backed insurance, unlocking cash flow and fueling a new wave of trade growth.

ADP's latest dividend declaration highlights its financial strength and commitment to shareholders, cementing its status as a reliable income-generating stock.

Universal Logistics Holdings appoints ex-Ford exec Michael Rogers as CFO, signaling a strategic pivot towards automotive and EV logistics expertise.

A new study reveals why GLP-1 drugs work for some and not others. 23andMe's research could personalize obesity treatment for millions of patients.

A single-dose therapy wiped out aggressive glioblastoma tumors in a landmark pre-clinical study, paving the way for human trials in 2026.

Ex-Global X exec Rob Oliver launches Aura ETFs. Its first fund, DUTY, taps into defense spending and donates 10% of fees to military veteran charities.

America First Credit Union hires legal and risk expert Jessica Graham, signaling a strategic move to navigate complex regulations and aggressive M&A growth.

As AI and automation reshape global tax, a new online certificate from IBFD and VU Amsterdam aims to equip professionals with crucial, future-proof skills.